Johnson & Johnson’s COVID-19 Vaccine Suspended After Blood Disorder Reports

Johnson & Johnson’s COVID-19 Vaccine  Suspended After Blood Disorder Reports

A manufacturing plant in Baltimore, Maryland where two experimental COVID-19 vaccines are manufactured has caused the U.S. Food and Drug Administration (FDA) to delay authorization of the plant’s production lines due to the contamination of 15 million doses of Johnson & Johnson’s (J&J) COVID-19 vaccine.1 Ingredients Used in Two COVID-19 Vaccines “Mixed Up” During Production […]